Unresectable Colorectal Cancer Synchronous Metastases: How to Manage the Primary Tumor

被引:0
作者
Idrees, Kamran [1 ]
Safar, Bashar [2 ]
Hawkins, William G. [1 ]
机构
[1] Washington Univ, Dept Surg, Sect Hepatobiliary Pancreat & Gastrointestinal Su, 660 S Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA
[2] Washington Univ, Dept Surg, Sect Colorectal Surg, St Louis, MO 63110 USA
关键词
Colorectal cancer; Synchronous disease; Prophylactic resection; Primary tumor; Metastatic disease; Unresectable;
D O I
10.1007/s11888-012-0125-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In patients with newly diagnosed colorectal cancer, a significant proportion of patients will present with disseminated disease. In the presence of a symptomatic primary tumor, resection may be required to alleviate the symptoms of obstruction, bleeding, or perforation. Historically, resection of the primary asymptomatic tumor was advocated because a large portion of patients eventually developed symptoms or complications related to their primary tumors. Resection was followed by adjuvant chemotherapy with 5FU and survival was modest. However, with the improved response rates to the newer cytotoxic systemic therapies the role of prophylactic resection of the primary tumor in unresectable stage IV colorectal cancer has been questioned. Newer data suggest that routine palliative resection of the synchronous primary lesion should not be performed in the absence of symptoms. Several questions remain and ongoing prospective randomized trials will likely address many of the limitations of currently available literature.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 29 条
[1]  
Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16
[2]   Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study [J].
Ahmed, Shahid ;
Ahmad, Imran ;
Zhu, Tong ;
Arnold, Florence P. ;
Anan, Ghadeer Faiz ;
Sami, Amer ;
Yadav, Sunil K. ;
Alvi, Riaz ;
Haider, Kamal .
DISEASES OF THE COLON & RECTUM, 2010, 53 (10) :1432-1438
[3]   Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases [J].
Benoist, S ;
Pautrat, K ;
Mitry, E ;
Rougier, P ;
Penna, C ;
Nordlinger, B .
BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1155-1160
[4]   RESECTION AND EMBOLIZATION IN THE MANAGEMENT OF SECONDARY HEPATIC-TUMORS [J].
BLUMGART, LH ;
ALLISON, DJ .
WORLD JOURNAL OF SURGERY, 1982, 6 (01) :32-45
[5]  
CADY B, 1970, SURG GYNECOL OBSTETR, V131, P697
[6]   Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: An analysis of surveillance, epidemiology, and end results data, 1988 to 2000 [J].
Cook, AD ;
Single, R ;
McCahill, LE .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (08) :637-645
[7]  
Dutch Colorectal CancerGroup (DCCG), CAIRO4 TRIAL ROL SUR
[8]   Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial [J].
Folprecht, Gunnar ;
Gruenberger, Thomas ;
Bechstein, Wolf O. ;
Raab, Hans-Rudolf ;
Lordick, Florian ;
Hartmann, Joerg T. ;
Lang, Hauke ;
Frilling, Andrea ;
Stoehlmacher, Jan ;
Weitz, Juergen ;
Konopke, Ralf ;
Stroszczynski, Christian ;
Liersch, Torsten ;
Ockert, Detlev ;
Herrmann, Thomas ;
Goekkurt, Eray ;
Parisi, Fabio ;
Koehne, Claus-Henning .
LANCET ONCOLOGY, 2010, 11 (01) :38-47
[9]   A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].
Goldberg, RM ;
Sargent, DJ ;
Morton, RF ;
Fuchs, CS ;
Ramanathan, RK ;
Williamson, SK ;
Findlay, BP ;
Pitot, HC ;
Alberts, SR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30
[10]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342